Literature DB >> 26772887

Cystathionine γ-lyase(CSE)/hydrogen sulfide system is regulated by miR-216a and influences cholesterol efflux in macrophages via the PI3K/AKT/ABCA1 pathway.

Duo Gong1, Hai-Peng Cheng1, Wei Xie1, Min Zhang1, Dan Liu1, Gang Lan1, Chong Huang1, Zhen-Wang Zhao1, Ling-Yan Chen1, Feng Yao1, Yu-Lin Tan1, Liang Li1, Xiao-Dan Xia1, Xi-Long Zheng2, Zong-Bao Wang3, Chao-Ke Tang4.   

Abstract

This study was designed to evaluate whether CSE/H2S system, which is regulated by miR-216a, regulated ABCA1-mediated cholesterol efflux and cholesterol contents in THP-1 macrophages-derived foam cells. Our qPCR and western blotting results showed that CSE/H2S significantly up-regulated the expression of ATP-binding cassette transporter A1 (ABCA1) mRNA and protein via PI3K/AKT pathway in foam cells derived from human THP-1 macrophages. The miR-216a directly targeted 3' untranslated region of CSE. It significantly reduced CSE and ABCA1 expression, and also decreased the phosphorylation of PI3K and AKT. Additionally, cholesterol efflux decreased, and cholesterol levels increased in THP-1 macrophage-derived foam cells in response to treatment with miR-216a. Our study demonstrates that CSE/H2S system is regulated by miR-216a, and regulates ABCA1-mediated cholesterol efflux and cholesterol levels through the PI3K/AKT pathway.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCA1; CSE; Cholesterol efflux; Endogenous H(2)S; PI3K/AKT pathway; miR-216a

Mesh:

Substances:

Year:  2016        PMID: 26772887     DOI: 10.1016/j.bbrc.2016.01.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Mechanisms of foam cell formation in atherosclerosis.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  J Mol Med (Berl)       Date:  2017-08-07       Impact factor: 4.599

Review 2.  Beyond a Gasotransmitter: Hydrogen Sulfide and Polysulfide in Cardiovascular Health and Immune Response.

Authors:  Shuai Yuan; Xinggui Shen; Christopher G Kevil
Journal:  Antioxid Redox Signal       Date:  2017-06-01       Impact factor: 8.401

3.  Hydrogen Sulfide and the Immune System.

Authors:  Peter Rose; Yi-Zhun Zhu; Philip K Moore
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.

Authors:  Qian Ding; Yi-Zhun Zhu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  MicroRNA-216a induces endothelial senescence and inflammation via Smad3/IκBα pathway.

Authors:  Shujun Yang; Xuenan Mi; Yu Chen; Congrui Feng; Zhihui Hou; Rutai Hui; Weili Zhang
Journal:  J Cell Mol Med       Date:  2018-03-07       Impact factor: 5.310

Review 6.  Intracellular and Plasma Membrane Events in Cholesterol Transport and Homeostasis.

Authors:  Dmitry Y Litvinov; Eugeny V Savushkin; Alexander D Dergunov
Journal:  J Lipids       Date:  2018-08-06

7.  Hydrogen sulfide inhibits PCSK9 expression through the PI3K/Akt‑SREBP‑2 signaling pathway to influence lipid metabolism in HepG2 cells.

Authors:  Jun Xiao; Xue-Qin Bai; Ling Liao; Min Zhou; Juan Peng; Qiong Xiang; Zhong Ren; Hong-Yan Wen; Zhi-Sheng Jiang; Zhi-Han Tang; Mei-Mei Wang; Lu-Shan Liu
Journal:  Int J Mol Med       Date:  2019-03-01       Impact factor: 4.101

8.  MicroRNA-216a Promotes Endothelial Inflammation by Smad7/IκBα Pathway in Atherosclerosis.

Authors:  Shujun Yang; Yu Chen; Xuenan Mi; Shuyuan Zhang; Yunyun Yang; Rutai Hui; Weili Zhang
Journal:  Dis Markers       Date:  2020-11-17       Impact factor: 3.434

9.  Hydrogen Sulfide Up-Regulates the Expression of ATP-Binding Cassette Transporter A1 via Promoting Nuclear Translocation of PPARα.

Authors:  Dong Li; Qinghui Xiong; Jin Peng; Bin Hu; Wanzhen Li; Yizhun Zhu; Xiaoyan Shen
Journal:  Int J Mol Sci       Date:  2016-04-29       Impact factor: 5.923

Review 10.  Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.

Authors:  Lei Zhang; Yanan Wang; Yi Li; Lingli Li; Suowen Xu; Xiaojun Feng; Sheng Liu
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.